Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
Zogenix Soars After Epilepsy Drug Meets Primary Endpoint
By Armie Margaret Lee
Sep 29, 2017 9:42 AM EDT
PRESS RELEASES
Prothena To Report Fourth Quarter And Full Year 2020 Financial Results And Host Webcast Conference Call On February 11th
By GlobeNewswire
Feb 4, 2021 4:05 PM EST
PRESS RELEASES
Prothena Announces Confirmatory Phase 3 AFFIRM-AL Study Of Birtamimab In Mayo Stage IV Patients With AL Amyloidosis Under SPA Agreement With FDA
By GlobeNewswire
Feb 1, 2021 4:15 PM EST
PRESS RELEASES
Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Dec 4, 2020 4:05 PM EST
PRESS RELEASES
Prothena Announces Presentations On Two Programs From Its Alzheimer's Disease Portfolio At CTAD 2020
By GlobeNewswire
Nov 4, 2020 8:30 AM EST
PRESS RELEASES
Prothena To Report Third Quarter 2020 Financial Results On November 4
By GlobeNewswire
Oct 28, 2020 4:05 PM EDT
PRESS RELEASES
Roche And Prothena Will Advance Prasinezumab Into Late-Stage Clinical Development Study In Parkinson's Disease
By GlobeNewswire
Oct 20, 2020 4:05 PM EDT
PRESS RELEASES
Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Oct 2, 2020 4:05 PM EDT
PRESS RELEASES
Prothena To Hold Investor Webcast To Discuss Results From Phase 2 PASADENA Study Presented At The International Parkinson And Movement Disorder Society's MDS Virtual Congress
By GlobeNewswire
Sep 15, 2020 8:30 AM EDT
PRESS RELEASES
Prasinezumab Slows Progression On Measures Of Parkinson's Disease In Phase 2 Study
By GlobeNewswire
Sep 11, 2020 8:30 AM EDT
PRESS RELEASES
Prothena To Present At The 2020 Cantor Virtual Global Healthcare Conference On September 15
By GlobeNewswire
Sep 8, 2020 4:05 PM EDT
PRESS RELEASES
Prothena Announces Updated Timing Of Presentation For Phase 2 PASADENA Study Results At International Congress Of Parkinson's Disease And Movement Disorders
By GlobeNewswire
Sep 3, 2020 4:05 PM EDT
PRESS RELEASES
Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
By GlobeNewswire
Sep 2, 2020 4:05 PM EDT
PRESS RELEASES
Prothena Announces Phase 2 PASADENA Study Results To Be Presented At International Congress Of Parkinson's Disease And Movement Disorders
By GlobeNewswire
Aug 5, 2020 4:05 PM EDT
PRESS RELEASES
Prothena To Report Second Quarter 2020 Financial Results On August 6
By GlobeNewswire
Jul 30, 2020 4:05 PM EDT
PRESS RELEASES
Prothena To Present At The Jefferies Virtual Healthcare Conference On June 3
By GlobeNewswire
May 27, 2020 4:05 PM EDT
PRESS RELEASES
Prothena To Report First Quarter 2020 Financial Results On May 6
By GlobeNewswire
Apr 29, 2020 4:05 PM EDT
PRESS RELEASES
Prothena Provides Additional Information Regarding Upcoming Annual General Meeting Of Shareholders In Response To COVID-19
By GlobeNewswire
Apr 24, 2020 4:30 PM EDT
PRESS RELEASES
Update On Phase 2 PASADENA Study Of Prasinezumab (PRX002/RG7935) In Parkinson's Disease
By GlobeNewswire
Apr 22, 2020 9:15 AM EDT
PRESS RELEASES
Baseline Data From Phase 2 PASADENA Study Of Prasinezumab (PRX002/RG7935) In Parkinson's Disease To Be Presented At AAT-AD/PD
By GlobeNewswire
Mar 31, 2020 4:05 PM EDT
PRESS RELEASES
Prothena Announces Appointment Of Brandon Smith As Chief Business Officer
By GlobeNewswire
Mar 3, 2020 4:05 PM EST
PRESS RELEASES
Prothena To Report Fourth Quarter And Full Year 2019 Financial Results And Host Webcast Conference Call On February 12
By GlobeNewswire
Feb 5, 2020 4:05 PM EST
STOCKS
Zogenix Soars After Epilepsy Drug Meets Primary Endpoint
By Armie Margaret Lee
Sep 29, 2017 9:42 AM EDT
HEALTH
Celgene, Vertex and Spark Among Jefferies' Top Biotech Picks
By Armie Margaret Lee
Jul 14, 2017 4:11 PM EDT
STOCKS
3 Stocks You Probably Never Heard Of Could Catch Fire Soon
By Roberto Pedone
Jun 22, 2017 11:03 AM EDT
